AnchorDx

company

About

AnchorDx is a precision medicine firm.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$28M
Industries
Biotechnology,Emergency Medicine,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Guangzhou Baseline Medical is committed to building a world-class clinical application of high-throughput sequencing and R & D platform to become the leading global provider of precision medical solutions. The company's core team has more than 20 years of senior industry experience, involved in cancer genomics, genetics and bioinformatics and other fields.

Based on its core technical advantages, the Company aims at precision medicine, establishes a cooperative relationship with middle and downstream enterprises in the industry, and forms a complete industrial chain from academic research to clinical product transformation. It has also established close cooperation with many large-scale third-party inspection agencies including Illumina, Well-known domestic and foreign hospitals and research institutes to establish cooperative relations, the development of a series of independent intellectual property rights and international competitiveness of clinical testing products for patients, doctors and medical institutions to provide accurate, convenient and comprehensive services.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$28M
AnchorDx has raised a total of $28M in funding over 2 rounds. Their latest funding was raised on Nov 7, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 7, 2017 Series B $28M 2 Sijia Jianxin Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
2
AnchorDx is funded by 2 investors. Sijia Jianxin Fund and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Sijia Jianxin Fund Yes Series B
ARCH Venture Partners Series B